Sciarra A - Search Results

1

Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis.

Del Giudice F, Busetto GM, Gross MS, Maggi M, Sciarra A, Salciccia S, Ferro M, Sperduti I, Flammia S, Canale V, Chung BI, Conti SL, Eisenberg ML, Skinner EC, De Berardinis E. Del Giudice F, et al. Among authors: sciarra a. J Cancer Res Clin Oncol. 2021 Oct;147(10):3073-3080. doi: 10.1007/s00432-021-03571-0. Epub 2021 Mar 6. J Cancer Res Clin Oncol. 2021. PMID: 33675400 Free PMC article. Clinical Trial.

2

Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.

Di Silverio F, Casale P, Colella D, Andrea L, Seccareccia F, Sciarra A. Di Silverio F, et al. Among authors: sciarra a. Cancer. 2000 Feb 15;88(4):835-43. doi: 10.1002/(sici)1097-0142(20000215)88:4<835::aid-cncr14>3.0.co;2-j. Cancer. 2000. PMID: 10679653

3

Chromogranin A expression in familial versus sporadic prostate cancer.

Sciarra A, Monti S, Gentile V, Salciccia S, Autran Gòmez AM, Pannunzi LP, Di Silverio F. Sciarra A, et al. Urology. 2005 Nov;66(5):1010-4. doi: 10.1016/j.urology.2005.05.045. Urology. 2005. PMID: 16286114

4

Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate.

Sciarra A, Salciccia S, Albanesi L, Cardi A, D'Eramo G, Di Silverio F. Sciarra A, et al. Urology. 2005 Dec;66(6):1218-22. doi: 10.1016/j.urology.2005.06.090. Urology. 2005. PMID: 16360446 Clinical Trial.

5

Complete response to the combination therapy with androgen blockade and somatostatin analogue in a patient with advanced prostate cancer: magnetic resonance imaging with 1H-spectroscopy.

Sciarra A, Panebianco V, Ciccariello M, Salciccia S, Gentilucci A, Lisi D, Passariello R, Gentile V, Di Silverio F. Sciarra A, et al. Eur Urol. 2008 Mar;53(3):652-5. doi: 10.1016/j.eururo.2007.02.010. Epub 2007 Feb 15. Eur Urol. 2008. PMID: 17316966

6

New treatment strategies in the management of hormone refractory prostate cancer (HRPC): only chemotherapy?

Sciarra A, Salciccia S. Sciarra A, et al. Eur Urol. 2007 Oct;52(4):945-7. doi: 10.1016/j.eururo.2007.03.029. Epub 2007 Mar 15. Eur Urol. 2007. PMID: 17376588 No abstract available.

7

Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report.

Sciarra A, Autran Gomez AM, Gentilucci A, Parente U, Salciccia S, Gentile V, Di Silverio F. Sciarra A, et al. Eur Urol. 2007 Aug;52(2):597-9. doi: 10.1016/j.eururo.2007.03.083. Epub 2007 Apr 4. Eur Urol. 2007. PMID: 17420088

8

Inflammation and chronic prostatic diseases: evidence for a link?

Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Sciarra A, et al. Eur Urol. 2007 Oct;52(4):964-72. doi: 10.1016/j.eururo.2007.06.038. Epub 2007 Jul 2. Eur Urol. 2007. PMID: 17618043 Review.

9

Prostate growth and inflammation.

Sciarra A, Mariotti G, Salciccia S, Autran Gomez A, Monti S, Toscano V, Di Silverio F. Sciarra A, et al. J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):254-60. doi: 10.1016/j.jsbmb.2007.09.013. Epub 2007 Sep 7. J Steroid Biochem Mol Biol. 2008. PMID: 17935971 Review.

10

Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia.

Sciarra A, Gentile V, Monti S, Dattilo C, Autran Gomez A, Salciccia S, Pannunzi LP, Toscano V, Di Silverio F. Sciarra A, et al. Urol Int. 2008;80(1):68-73. doi: 10.1159/000111733. Epub 2008 Jan 18. Urol Int. 2008. PMID: 18204237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page